Cardiac Diseases Completed Phase 3 Trials for Atenolol (DB00335)

Also known as: Cardiac Disease

IndicationStatusPhase
DBCOND0029283 (Cardiac Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01202721Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)Prevention